Reconstructed Energy successfully listed on the Hong Kong Stock Exchange, raising HKD 12.8 billion and solidifying its position as a pioneer in the hydrogen fuel technology industry.

Target Company Overview

Reconstructed Energy (02570.HK), a leading hydrogen technology enterprise founded in September 2015, made its successful debut on the Hong Kong Stock Exchange on December 6, 2024. The company offered 4.82792 million H-shares at a price of HKD 148.9 per share, resulting in a market capitalization exceeding HKD 12.8 billion. Under the leadership of Chairman Lin Qi and President Hu Zhe, Reconstructed Energy is recognized as a specialized and innovative 'little giant' enterprise at the national level. It holds the distinction of being China’s only manufacturing champion in the fuel cell sector.

With a strong global vision, Reconstructed Energy has an exemplary research and development team that operates manufacturing bases in Shanghai, Changshu, and Jiaxing, alongside international branches in North America and Europe. It is the first in the industry to achieve comprehensive self-research and mass production of fuel cell systems, stacks, membrane electrodes, and bipolar plates, marking its dominance in the Chinese hydrogen fuel cell system market in 2023 with the highest total output power sold.

Industry Overview in China

The hydrogen energy industry in China is rapidly evolving as a crucial component of the nation’s energy strategy. Hydrogen is recognized for its clean energy capabilities, boasting benefits such as zero emissions during energy conversion, high effic

View Source

Similar Deals

君联资本 重塑能源

2024

Public-to-Private (P2P) Hydrogen Fuel China
CM Venture Guofu Hydrogen

2024

Public-to-Private (P2P) Hydrogen Fuel China
Qiming Venture Partners LanzaTech Global, Inc.

2023

Public-to-Private (P2P) Renewable Fuels (NEC) China
启明创投 壁仞科技

2026

Public-to-Private (P2P) Processors China
MiniMax Group Inc. MiniMax Group Inc.

2026

Public-to-Private (P2P) Machine Learning & Artificial Intelligence (AI) Services China
磐霖资本 瑞博生物

2026

Public-to-Private (P2P) Proprietary & Advanced Pharmaceuticals China

君联资本 (Qinlian Capital)

invested in

重塑能源 (Reformed Energy)

in 2024

in a Public-to-Private (P2P) deal

Disclosed details

Transaction Size: $1,646M

Enterprise Value: $1,646M

Equity Value: $1,646M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert